High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab

Molecular cancer research : MCR

Chung-Han Lee, Renzo G DiNatale, Diego Chowell, …, A Ari Hakimi, Robert J Motzer, Timothy A Chan

• DOI: 10.1158/1541-7786.mcr-21-0053
• PMID: 34039647
• PMCID: PMC8419018